Follow The Filings

SYK Stryker

Health Care, filed as STRYKER CORPORATION (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 4

  • 1 Owner
  • #253
  • Max 0.1%
  • Master 0.07%
  • $156K

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. 0.08%

Who owns SYK

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.08% Hold 568 $156K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by SYK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SYK insider trades
  • None no insider bought on the open market
  • $585M sold by 7 insiders outside a trading plan
  • $1.4M sold by 1 insider under 10b5-1 plans
  1. Mary K Brainerd Director
    Buy
    $27K 131 shares at $204.09 New stake
    Traded Jun 26, 2019–Nov 22, 2022 Filed Sep 2
    ↗
  2. Dylan Bram Crotty Group President
    Sale
    $145K 441 shares at $328.61 6.7% of stake
    Traded Aug 21 Filed Aug 26
    ↗
  3. Ronda E Stryker Director
    Sale
    $118M 350,000 shares at $336.50 14% of stake
    Traded Aug 18–19 Filed Aug 20
    ↗
  4. Debra King See Remarks
    Sale
    $278K 826 shares at $336.30 12% of stake
    Traded Aug 18 Filed Aug 18
    ↗
  5. Robert S Fletcher VP, Chief Legal Officer
    Planned sale
    $1.4M 4,544 shares at $306.87 30% of stake
    Traded May 28 Filed May 29
    ↗
  6. Ronda E Stryker Director
    Sale
    $96.8M 310,000 shares at $312.23 11% of stake
    Traded May 26 Filed May 28
    ↗
  7. M Kathryn Fink VP, Chief HR Officer
    Sale
    $2.5M 8,720 shares at $283.69
    Traded May 11 Filed May 12
    ↗
  8. Ronda E Stryker Director
    Sale
    $182M 500,000 shares at $363.44 19% of stake
    Traded Feb 4–5 Filed Feb 6
    ↗
  9. James Andrew Pierce Group President
    Sale
    $175K 475 shares at $368.87 0.7% of stake
    Traded Feb 2 Filed Feb 3
    ↗
  10. Preston Wendell Wells CFO
    Sale
    $60K 165 shares at $365.88 2.4% of stake
    Traded Nov 20, 2025 Filed Nov 20, 2025
    ↗
  11. William E Berry Jr. VP, Chief Accounting Officer
    Sale
    $714K 1,953 shares at $365.49 41% of stake
    Traded Nov 14, 2025 Filed Nov 17, 2025
    ↗
  12. Ronda E Stryker Director
    Sale
    $185M 520,000 shares at $355.01 16% of stake
    Traded Nov 5–6 Filed Nov 7, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 22 share withholdings for taxes, 19 stock grants, 14 option exercises, 7 gifts, and 4 other transactions.

Congress

8 members of Congress traded SYK in the last three years: 8 buys and 16 sales. 10 members listed it in 2025 annual reports.

All Congress trades
  1. Thomas H. Kean, Jr. R-NJ-7 Partial sale $1K–$15K Jul 22 filed Aug 18
  2. Alan Armstrong R-OK Sell $15K–$50K Mar 27 filed Jul 21
  3. Thomas H. Kean, Jr. R-NJ-7 Partial sale $1K–$15K Jun 2 filed Jul 15
  4. Thomas H. Kean, Jr. R-NJ-7 Partial sale $15K–$50K Jan 23 filed Feb 19
  5. Julia Letlow R-LA-5 Sell $1K–$15K Oct 16, 2025 filed Jan 13
  6. Julia Letlow R-LA-5 Buy $1K–$15K Oct 23, 2024 filed Jan 13

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K/A 1.05,7.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated about 11 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $20.5B $22.6B $25.12B
Gross profit $13.06B $14.44B $16.06B
Gross margin * 63.7% 63.9% 64.0%
Net income $3.16B $2.99B $3.25B
Net margin * 15.4% 13.2% 12.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $12.52B $14.85B $14.76B
Total non-current assets * $27.39B $28.12B $33.09B
Total assets $39.91B $42.97B $47.84B
Total current liabilities $7.92B $7.62B $7.79B
Total non-current liabilities * $13.4B $14.72B $17.63B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $3.71B $4.24B $5.04B
Cash from investing -$0.962B -$3B -$4.87B
Cash from financing -$1.59B -$0.525B $0.113B
Net change in cash $1.13B $0.681B $0.359B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.